An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
| Image |  |
|---|---|
| Description | scientific article published on 06 September 2018 |
| Author/s |
author: James Spicer Richard Baird |
| Publication date | September 6, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |